Current Analysis: Haleon


Image Source: PixabayTM Editors’ note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence.Haleon (HLN) is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022.The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity.Overall, Haleon’s brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022.Haleon plc was incorporated in 2021 and is headquartered in Weybridge, the United Kingdom.Three key data points gaugeHaleon PLC or any dividend-paying firm.The key three are:(1) Price(2) Dividends(3) ReturnsThose three basic keys best tell whether any company has made, is making, and will make money.HLN PriceOver the past year, Haleon PLC share price rose 13.8% from $7.60 to $8.66 as of Tuesday’s market close.If Haleon PLC shares trade in the range of $5.50 to $9.50 this next year, its recent $8.66 share price might rise to $9.00 by next year. Of course, Haleons price could drop about the same $0.34 estimated amount, or more.My annual upside estimate of $0.34 however, coincides with the amount required to match Haleon’s all-time high price.HLN DividendHaleon PLC has paid variable semi-annual dividends since April, 2023. Haleon’s recent SA dividend of $0.11 was declared February 29th 2024 to shareholders of record March 14th. The payout is coming May 16th.  There’s a small window to get in on the 2024 full dividend.The forward looking $0.22 annual dividend yields 2.54% at Tuesday’s $8.66 share price.HLN ReturnsTo put it all together, add Haleon PLC’s estimated annual dividend of $0.22 to the estimated price upside of $0.34 to find a $0.56 gross gain.At Friday’s $8.66 share price, a little under $1000 would buy 115 shares.A $10 broker fee (if charged), paid half at purchase and half at sale, would cost us  $0.09 per share.Subtracting that likely $0.09 brokerage cost from the $0.56 gross gain produces a net gain of $0.47 X 115 shares = $54.05 for a 5.4% estimated net gain.You might choose to pounce on Haleon PLC. It is a 3 year old dividend paying United Kingdom consumer health firm with power brands.  Furthermore, the estimated $25.40 annual dividend income from $1k invested is almost 3 times greater than Haleon’s recent $8.66 single share price.The exact track of Haleon’s ongoing future price and dividend will be determined by market action.Remember the true value of any stock is best realized through personal ownership of shares.More By This Author:Current Analysis: Getinge AB
Current Analysis: Elekta AB (EKTAF)
Current Analysis: Telenor

Reviews

  • Total Score 0%
User rating: 0.00% ( 0
votes )



Leave a Reply

Your email address will not be published. Required fields are marked *